Quince Therapeutics, Inc. Soared
Tue, Feb 10, 2026 at 07:18 PM
Quince Therapeutics, Inc. (QNCX:NASDAQ) soared at $0.53, representing a gain of 305.9%. The stock got featured on our News Catalysts scanner on Tue, Feb 10, 2026 at 08:22 AM in the 'MISCELLANEOUS' category. From Tue, Jan 27, 2026, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Jan 20, 2026 at $3.72 with a volume of 1M+.
About Quince Therapeutics, Inc. (QNCX:NASDAQ)
Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases.
Top 10 Gainers:
- Quince Therapeutics, Inc. (QNCX:NASDAQ), 305.92%
- Jiuzi Holdings, Inc. (JZXN:NASDAQ), 89.71%
- Evommune Inc. (EVMN:NYSE), 70.87%
- TuHURA Biosciences, Inc. (HURA:NASDAQ), 60.47%
- Founder Group Limited (FGL:NASDAQ), 55.96%
- Nektar Therapeutics (NKTR:NASDAQ), 51.07%
- ZW Data Action Technologies Inc. (CNET:NASDAQ), 49.99%
- SRx Health Solutions Inc. (SRXH:NYSEMKT), 45.55%
- BiomX Inc. (PHGE:NYSEMKT), 44.37%
- European Wax Center, Inc. (EWCZ:NASDAQ), 43%